Clinical Trial Update: ACURATE neo2™ Post Market Clinical Follow up Study

View source ↗

Summary

Post-market clinical follow-up study for the ACURATE neo2 aortic valve replacement device by Boston Scientific, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Diseases
• Aortic Valve Calcification
• Aortic Valve Stenosis

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Aortic Valve Stenosis, Aortic Valve Calcification | Status: ACTIVE_NOT_RECRUITING